During the past decade, Neurological Services of Orlando conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurological Services of Orlando" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Alexion" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Immunovant Sciences GmbH" with 1 trials sponsored and "Mallinckrodt" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Services of Orlando" #1 collaborator was "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Neurological Services of Orlando" are "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Neuromyelitis Optica" (2 trials), "Neuromyelitis Optica Spectrum Disorder" (2 trials) and "Autoimmune Diseases of the Nervous System" (1 trials). Many other conditions were trialed in "Neurological Services of Orlando" in a lesser frequency.

Most popular intervention types in "Neurological Services of Orlando" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Placebo" (5 trials), "Cemdisiran" (1 trials), "Eculizumab" (1 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Services of Orlando" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Neurological Services of Orlando". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Neurological Services of Orlando, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Services of Orlando, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".